The cardiac maladaptive ATF3-dependent cross-talk between cardiomyocytes and macrophages is mediated by the IFNγ-CXCL10-CXCR3 axis

International Journal of Cardiology

Volumn 228, Issue , 2017, Pages 394-400

  Koren, L ^a   Barash, U ^a   Zohar, Y ^a,b   Karin, N ^a   Aronheim, A ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Rambam Health Care Campus ^*  (Israel)

Author keywords

ATF3; Cardiac remodeling; Cardiomyocytes; Macrophages; Phenylephrine; Pressure overload

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; ATF3 PROTEIN, MOUSE; CXCL10 PROTEIN, MOUSE; CXCR3 PROTEIN, MOUSE; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CARDIAC MUSCLE CELL; CELL VOLUME; CONTROLLED STUDY; DISEASE ACTIVITY; EMBRYO; HEART LEFT VENTRICLE OVERLOAD; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CARDIOMEGALY; CELL CULTURE; CONFOCAL MICROSCOPY; DISEASE MODEL; FLOW CYTOMETRY; GENETICS; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; WESTERN BLOTTING;

ACTIVATING TRANSCRIPTION FACTOR 3; ANIMALS; BLOTTING, WESTERN; CARDIOMEGALY; CELLS, CULTURED; CHEMOKINE CXCL10; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; MYOCYTES, CARDIAC; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CXCR3; RNA, MESSENGER; SIGNAL TRANSDUCTION; VENTRICULAR REMODELING;

EID: 84995783995     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.11.159     Document Type: Article

References (20)

1. [1] Frey, N., Katus, H.A., Olson, E.N., Hill, J.A., Hypertrophy of the heart: a new therapeutic target?. Circulation 109 (2004), 1580–1589.
2. [2] Frey, N., Olson, E.N., Cardiac hypertrophy: the good, the bad, and the ugly. Annu. Rev. Physiol. 65 (2003), 45–79.
3. [3] Maillet, M., van Berlo, J.H., Molkentin, J.D., Molecular basis of physiological heart growth: fundamental concepts and new players. Nat. Rev. Mol. Cell Biol. 14 (2013), 38–48.
4. [4] Kehat, I., Molkentin, J.D., Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation 122 (2010), 2727–2735.
5. [5] Koren, L., Alishekevitz, D., Elhanani, O., Nevelsky, A., Hai, T., Kehat, I., et al. ATF3-dependent cross-talk between cardiomyocytes and macrophages promotes cardiac maladaptive remodeling. Int. J. Cardiol. 198 (2015), 232–240.
6. [6] Koren, L., Elhanani, O., Kehat, I., Hai, T., Aronheim, A., Adult cardiac expression of the activating transcription factor 3, ATF3, promotes ventricular hypertrophy. PLoS ONE, 8, 2013, e68396.
7. [7] Yin, T., Sandhu, G., Wolfgang, C.D., Burrier, A., Webb, R.L., Rigel, D.F., et al. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J. Biol. Chem. 272 (1997), 19943–19950.
8. [8] Chen, S.C., Liu, Y.C., Shyu, K.G., Wang, D.L., Acute hypoxia to endothelial cells induces activating transcription factor 3 (ATF3) expression that is mediated via nitric oxide. Atherosclerosis 201 (2008), 281–288.
9. [9] Hasin, T., Elhanani, O., Abassi, Z., Hai, T., Aronheim, A., Angiotensin II signaling up-regulates the immediate early transcription factor ATF3 in the left but not the right atrium. Basic Res. Cardiol. 106 (2011), 175–187.
10. [10] Zhou, H., Shen, D.F., Bian, Z.Y., Zong, J., Deng, W., Zhang, Y., et al. Activating transcription factor 3 deficiency promotes cardiac hypertrophy, dysfunction, and fibrosis induced by pressure overload. PLoS One, 6, 2011, e26744.
11. [11] Hartman, M.G., Lu, D., Kim, M.L., Kociba, G.J., Shukri, T., Buteau, J., et al. Role for activating transcription factor 3 in stress-induced beta-cell apoptosis. Mol. Cell. Biol. 24 (2004), 5721–5732.
12. [12] Hancock, W.W., Lu, B., Gao, W., Csizmadia, V., Faia, K., King, J.A., et al. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J. Exp. Med. 192 (2000), 1515–1520.
13. [13] Kabaeva, Z., Zhao, M., Michele, D.E., Blebbistatin extends culture life of adult mouse cardiac myocytes and allows efficient and stable transgene expression. Am. J. Phys. Heart Circ. Phys. 294 (2008), H1667–H1674.
14. [14] Barash, U., Zohar, Y., Wildbaum, G., Beider, K., Nagler, A., Karin, N., et al. Heparanase enhances myeloma progression via CXCL10 downregulation. Leukemia 28 (2014), 2178–2187.
15. [15] Zohar, Y., Wildbaum, G., Novak, R., Salzman, A.L., Thelen, M., Alon, R., et al. CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis. J. Clin. Invest. 124 (2014), 2009–2022.
16. [16] Weidenfeld-Baranboim, K., Hasin, T., Darlyuk, I., Heinrich, R., Elhanani, O., Pan, J., et al. The ubiquitously expressed bZIP inhibitor, JDP2, suppresses the transcription of its homologue immediate early gene counterpart, ATF3. Nucleic Acids Res. 37 (2009), 2194–2203.
17. [17] Liu, M., Guo, S., Hibbert, J.M., Jain, V., Singh, N., Wilson, N.O., et al. CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev. 22 (2011), 121–130.
18. [18] van den Borne, P., Quax, P.H., Hoefer, I.E., Pasterkamp, G., The multifaceted functions of CXCL10 in cardiovascular disease. Biomed. Res. Int., 2014, 2014, 893106.
19. [19] Wolfgang, C.D., Liang, G., Okamoto, Y., Allen, A.E., Hai, T., Transcriptional autorepression of the stress-inducible gene ATF3. J. Biol. Chem. 275 (2000), 16865–16870.
20. [20] Yang, T., Li, Z.N., Chen, G., Gu, Q., Ni, X.H., Zhao, Z.H., et al. Increased levels of plasma CXC-Chemokine Ligand 10, 12 and 16 are associated with right ventricular function in patients with idiopathic pulmonary arterial hypertension. Heart Lung 43 (2014), 322–327.